MM
Mridula Mehrishi
About Mridula Mehrishi
Data last updated:
Mridula Mehrishi has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Zenta Healthcare Private Limited and Zyprus Pharma Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Zenta Healthcare Private Limited at ₹17.21 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Jul 2020 | 2004 | ₹17.21 Cr (FY 2025) | Active | |
| Director | 13 Jun 2023 | 2023 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mridula Mehrishi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mridula Mehrishi
Mridula Mehrishi has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Zenta Healthcare Private Limited and Zyprus Pharma Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Zenta Healthcare Private Limited at ₹17.21 Cr (FY 2025).
Mridula Mehrishi is associated with 2 companies as Director, including Zenta Healthcare Private Limited (₹17.21 Cr), Zyprus Pharma Private Limited.
Mridula Mehrishi has expertise in Healthcare, General Business.
Mridula Mehrishi has 6 years in corporate governance.
By reported revenue, the largest current company of Mridula Mehrishi is Zenta Healthcare Private Limited, with revenue of ₹17.21 Cr (FY 2025).
Mridula Mehrishi currently holds positions at 2 companies: Zenta Healthcare Private Limited (₹17.21 Cr), Zyprus Pharma Private Limited.